Sciele Pharma, Inc.
Five Concourse Parkway
Suite 1800
Atlanta
Georgia
30328
United States
Tel: 800-461-3696
Website: http://www.sciele.com/
107 articles about Sciele Pharma, Inc.
-
Shionogi Pharma, Inc. to Halve US Sales Force as Generics Hit Former Sciele Pharma, Inc. Business
9/8/2010
-
Sciele Pharma, Inc., a Shionogi Group Company, Announces Name Change to Shionogi Pharma, Inc.
1/12/2010
-
Sciele Pharma, Inc. Introduces Adrenaclick(TM) (epinephrine injection, USP) Auto-Injector for the Emergency Treatment of Anaphylaxis
1/7/2010
-
Pivotal Study For Sciele Pharma, Inc.'s PSD502 -- The First Potential Treatment For Premature Ejaculation
11/19/2009
-
Sciele Pharma, Inc., a Shionogi & Co., Ltd. Company, to Acquire Addrenex Pharmaceuticals, a U.S. Specialty Pharmaceutical Company
11/16/2009
-
Sciele Pharma, Inc. Submits New Drug Application to FDA for Glycopyrrolate Oral Solution, a Treatment for Chronic, Moderate-to-Severe Drooling in Pediatric Patients
9/28/2009
-
Sciele Pharma, Inc. Announces Availability of ULESFIA(TM)
8/5/2009
-
Sciele Pharma, Inc. and Plethora Solutions Holdings Announce Positive Results of Final Phase III Pivotal Trial for PSD502 for Premature Ejaculation
7/29/2009
-
Sciele Pharma, Inc. Says Scraps $150 Million Plan to Buy Victory Pharma, Inc.
7/10/2009
-
Sciele Pharma, Inc. Announces Availability of Ulesfia (Benzyl Alcohol Lotion 5%), First Prescription Non-Neurotoxic Head Lice Treatment
7/9/2009
-
Sciele Pharma, Inc. Acquires Global Rights for PSD502 from Plethora Solutions Ltd.
5/26/2009
-
Sciele Pharma, Inc., a Shionogi & Co., Ltd. Company, to Acquire Victory Pharma, Inc., a U.S. Specialty Pharmaceutical Company
5/18/2009
-
Sciele Pharma, Inc. to Acquire Victory Pharma, Inc. a U.S. Specialty Pharmaceutical Company for $150 Million
5/18/2009
-
Sciele Pharma, Inc. And Plethora Solutions Holdings Announce That PSD502 Demonstrates Substantial Benefit in the Treatment of Premature Ejaculation
4/28/2009
-
Sciele Pharma, Inc. and Addrenex Pharmaceuticals Announce Positive Phase III Clinical Results of Clonicel Used in Combination with Stimulants to Treat ADHD
4/23/2009
-
FDA Approves Sciele Pharma, Inc.'s Benzyl Alcohol Lotion for the Treatment of Head Lice
4/10/2009
-
Sciele Pharma, Inc. and Plethora Solutions Holdings Announce Completion of Patient Recruitment for Global Phase III Trial of PSD502 for Premature Ejaculation
2/18/2009
-
Novo Nordisk A/S And Sciele Pharma, Inc. Release: PrandiMet(R), First Repaglinide and Metformin HCl Fixed Dose Combination Therapy, Now Available in the United States
2/4/2009
-
Sciele Pharma, Inc. and Plethora Solutions Holdings Announce Final Analysis of PSD502 for Premature Ejaculation; All Primary and Secondary Endpoints Met in Phase III Pivotal Trial
12/8/2008
-
Sciele Pharma, Inc. Announces That Addrenex Pharmaceuticals Initiates Phase II Clinical Trial of ADX415 for the Treatment of Hypertension
10/23/2008